Life Sciences Times

Vertex Reports CASGEVY Data in Children Ages 5 to 11, Announces Additional Regulatory Submissions

Takeda Says Zasocitinib Outperformed Deucravacitinib in Phase 3 Psoriasis Study

PharmaEssentia Expands North American Presence With FORUS Therapeutics Acquisition

CTC Expands Outside Massachusetts With Epic Go-Lives at Two North Carolina Community Health Centers

Cellares Joins Alliance Focused on U.S. Biopharmaceutical Manufacturing

PharmaEssentia Wins Taiwan Approval for BESREMi in Essential Thrombocythemia

Orionis Biosciences, Novartis Expand Collaboration to Develop Molecular Glue Medicines

FDA Accepts Takeda Application for Pediatric ENTYVIO in Ulcerative Colitis and Crohn’s Disease

Sensorion Selects SENS-601 as Lead Gene Therapy Program for Genetic Hearing Loss

Predicta Biosciences, CIMA LAB Diagnostics Partner to Advance Blood-Based Diagnostics for Blood Cancers